Intelligence · Clinical Pipeline
Ningbo Cancer Hospital Pipeline
All ClinicalTrials.gov programs at Ningbo Cancer Hospital — phase, modality, and trial IDs.
- Programs
- 2
Quick answer
Ningbo Cancer Hospital has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets
Ningbo Cancer Hospital
Early Breast Cancer
1 trial -
SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation
Ningbo Cancer Hospital
Gastroenteropancreatic neuroendocrine tumors
1 trial
Frequently asked questions
How many pipeline programs does Ningbo Cancer Hospital have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs